Market revenue in 2023 | USD 16.3 million |
Market revenue in 2030 | USD 26.1 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 67.48% in 2024. Horizon Databook has segmented the Germany bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The bronchial biopsy devices market growth in Germany can be attributed to the country’s leading position in medical technology innovation and manufacturing. Germany’s robust healthcare system and high healthcare spending ensure widespread access to advanced bronchial biopsy devices across urban & rural areas. Major German cities like Berlin and Munich host some of Europe’s top medical research centers.
German manufacturers, including Karl Storz and Richard Wolf GmbH, are some of the key players in the market, offering cutting-edge biopsy devices widely used in hospitals and clinics. The prevalence of respiratory diseases in Germany due to smoking and industrial pollution underscores the need for effective diagnostic tools, driving market demand.
Moreover, Germany’s commitment to precision medicine and individualized patient care is reflected in the growing adoption of bronchial biopsy devices that offer high diagnostic accuracy. The country’s stringent regulatory environment, governed by institutions like the Federal Institute for Drugs and Medical Devices (BfArM), ensures that all bronchial biopsy devices meet rigorous safety and performance standards.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Germany bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account